Gsk Q1 2025 Results Investor Call

Gsk Q1 2025 Results Investor Call. This compares to earnings of $0.90 per. In q1, we delivered growth across all our product areas and regions with gbp 7.4 billion of sales, up 13% versus last year, excluding covid solutions.

Gsk (gsk) came out with quarterly earnings of $1.09 per share, beating the zacks consensus estimate of $0.94 per share. Eps of $1.03 beats by $0.07 | revenue of $12.27b (18.61% y/y) beats by $617.80m.